Correlations between versican and serum CA125 expressions and clinicopathological characteristics in patients with endometrioid adenocarcinoma

LI Jing-ling; WEI Hai-ming; ZHAO Ren-feng

doi:10.3969/j.issn.1674-3806.2020.07.08

Home>Articles>Correlations between versican and serum CA125 expressions and clinicopathological characteristics in patients with endometrioid adenocarcinoma

DOI: 10.3969/j.issn.1674-3806.2020.07.08

Correlations between versican and serum CA125 expressions and clinicopathological characteristics in patients with endometrioid adenocarcinoma

LI Jing-ling

WEI Hai-ming

ZHAO Ren-feng

Machine-generated Keywords：

Publication Date：2020-07-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 680-683 )

Chinese Journal of New Clinical Medicine

ISSN：1674-3806

Year, Vol.(Issue)：2020,13(7)